Advertisement

Pantoprazole Tablets

[18 November 2015]

Products Affected - Description

Pantoprazole Tablets, Actavis
40 mg tablets, 1000 count (NDC 45963-0570-05) - discontinued   
 
Pantoprazole tablet, Caraco
40 mg, 90 count (NDC 47335-0580-81) - discontinued
 
Pantoprazole Tablets, Kremers Urban
20 mg tablets, 90 count (NDC 62175-0180-46)
 
Pantoprazole tablet, Major
40 mg, 100 count (NDC 00904-6235-61) - discontinued

Pantoprazole Tablets, Prasco
20 mg tablets, 90 count (NDC 00008-0606-01) - discontinued
40 mg tablets, 90 count (NDC 00008-0607-01) - discontinued
40 mg tablets, 100 count, unit-dose (NDC 00008-0607-04) - discontinued

Pantoprazole Tablets, Teva
40 mg tablets, 90 count (NDC 00093-0012-98)

Reason for the Shortage

  • Aurobindo and Teva could not provide a reason for the shortage.
  • Actavis discontinued pantoprazole 20 mg tablets in October 2014.
  • Caraco has a new NDC number for pantoprazole 40 mg tablets.
  • Kremers Urban state the shortage is due to increased demand.
  • FDA imposed an import ban in mid-2013 on several Wockhardt products including pantoprazole.
  • Major has a new NDC number for pantoprazole 40 mg tablets.

Available Products

Protonix Tablets, Pfizer
20 mg tablets, 90 count (NDC 00008-0843-81)
40 mg, 90 count (NDC 00008-0841-81)
40 mg tablets, 100 count (NDC 00008-0841-99)
 
Pantoprazole tablet, Actavis
40 mg, 90 count (NDC 45963-0570-08)
 
Pantoprazole Tablets, Aurobindo
20 mg tablets, 90 count (NDC 65862-0559-90)
40 mg, 90 count (NDC 65862-0560-90)
 
Pantoprazole Tablets, Cadista
20 mg, 90 count (NDC 59746-0283-90)
40 mg, 90 count (NDC 59746-0284-90)

Pantoprazole Tablets, Camber
20 mg, 90 count (NDC 31722-0712-90)
40 mg, 90 count (NDC 31722-0713-90)
 
Pantoprazole tablet, Caraco
40 mg, 90 count (NDC 62756-0580-81)
 
Pantoprazole Tablets, Dr. Reddy’s
20 mg, 90 count (NDC 55111-0332-90)
40 mg, 90 count (NDC 55111-0333-90)

Pantoprazole Tablets, Kremers Urban
40 mg tablets, 90 count (NDC 62175-0617-46)
40 mg tablets, 1000 count (NDC 62175-0617-43)
 
Pantoprazole tablet, Major
40 mg, 100 count (NDC 00904-6474-61)
 
Pantoprazole Tablets, Mylan
20 mg tablets, 90 count (NDC 00378-6688-77)
40 mg tablets, 90 count (NDC 00378-6689-77)
40 mg tablets, 1000 count (NDC 00378-6689-10)
 
Pantoprazole Tablets, Mylan Institutional
40 mg tablets, 100 count (NDC 51079-0051-20)

Pantoprazole tablet, Teva
20 mg, 90 count (NDC 00093-0011-98)
 
Pantoprazole Tablets, Torrent
20 mg tablets, 90 count (NDC 13668-0096-90)
40 mg tablets, 90 count (NDC 13668-0429-90)

Estimated Resupply Dates

  • Actavis has pantoprazole 40 mg tablets on back order and the company cannot estimate a release date.
  • Kremers Urban is allocating pantoprazole 20 mg tablets weekly. 
  • Teva has pantoprazole 40 mg tablets on intermittent back order and the company is releasing product as it becomes available.

Related Shortages

Updated

November 18 and 11, October 20, August 21, July 22, June 5, May 13, March 4, January 9, 2015; November 26, October 15, September 16, August 1 and 15, July 9, June 5 and 26, May 5, April 15 and 28, March 28, February 4 and 27, 2014; December 4 and 18, November 8 and 11, September 3 and 26, August 1 and 20, July 2, June 27, May 10 and 22, April 3, March 1, February 1 and 14, January 11 and 25, 2013; December 5 and 19, 2012, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement